These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33573613)

  • 41. [Comparative performance of tuberculin skin test and QuantiFERON TB-gold in contact investigations for tuberculosis].
    Komukai J; Matsumoto K; Tomihara A; Miyake Y; Tatsumi T; Arima K; Danno K; Hirota S; Yoshida H; Koda S; Terakawa K; Shimouchi A
    Kekkaku; 2011 Nov; 86(11):847-56. PubMed ID: 22250463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon-gamma release assay for detection of latent tuberculosis infection in casual and close contacts of tuberculosis cases.
    Abu-Taleb AM; El-Sokkary RH; El Tarhouny SA
    East Mediterr Health J; 2011 Oct; 17(10):749-53. PubMed ID: 22256408
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concordance between tuberculin skin test and interferon-γ assay and interferon-γ response to mitogen in pediatric tuberculosis contacts.
    Thomas B; Pugalenthi A; Patel H; Woltmann G; Bankart J; Hoskyns W
    Pediatr Pulmonol; 2011 Dec; 46(12):1225-32. PubMed ID: 21681979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating UK National Guidance for Screening of Children for Tuberculosis. A Prospective Multicenter Study.
    Kampmann B; Seddon JA; Paton J; Nademi Z; Keane D; Williams B; Williams A; Liebeschutz S; Riddell A; Bernatoniene J; Patel S; Martinez N; McMaster P; Basu-Roy R; Welch SB
    Am J Respir Crit Care Med; 2018 Apr; 197(8):1058-1064. PubMed ID: 29190430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative Analysis of Gamma Interferon Release Assay Response in Children with Latent and Active Tuberculosis.
    Lombardi G; Petrucci R; Corsini I; Bacchi Reggiani ML; Visciotti F; Bernardi F; Landini MP; Cazzato S; Dal Monte P
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29142046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of QuantiFERON(®)-TB Gold In-Tube in tuberculosis contact investigation: experience in a tuberculosis unit.
    Gonzślez-Moreno J; García-Gasalla M; Gállego-Lezaun C; Fernández-Baca V; Mir Viladrich I; Cifuentes-Luna C; Serrano Bujalance A; Salom Vallespir A; Payeras Cifre A
    Infect Dis (Lond); 2015 Apr; 47(4):244-51. PubMed ID: 25692351
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting.
    Sharma SK; Vashishtha R; Chauhan LS; Sreenivas V; Seth D
    PLoS One; 2017; 12(1):e0169539. PubMed ID: 28060926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil.
    Costa AG; Carvalho BKS; Araújo-Pereira M; Ibiapina HNS; Spener-Gomes R; Souza AB; Gomes-Silva A; Andrade AMS; Silva EC; Arriaga MB; Benjamin A; Rocha MS; Moreira ASR; Oliveira JG; Figueiredo MC; Turner MM; Durovni B; Cavalcante S; Kritski AL; Rolla VC; Sterling TR; Andrade BB; Cordeiro-Santos M;
    Microbiol Spectr; 2021 Dec; 9(3):e0116321. PubMed ID: 34851140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Household tuberculosis contact investigation in a tuberculosis-prevalent country: Are the tuberculin skin test and interferon-gamma release assay enough in elderly contacts?
    Eom JS; Kim I; Kim WY; Jo EJ; Mok J; Kim MH; Lee K; Kim KU; Park HK; Lee MK
    Medicine (Baltimore); 2018 Jan; 97(3):e9681. PubMed ID: 29505017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of IGRA and TST in the diagnosis of latent tuberculosis among women of reproductive age in South India.
    Prakash Babu S; Ezhumalai K; Raghupathy K; Sundaresan M; Jain K; Narasimhan PB; Knudsen S; Horsburgh CR; Hochberg NS; Salgame P; Ellner J; Sarkar S
    Indian J Tuberc; 2023 Jan; 70(1):12-16. PubMed ID: 36740307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis.
    Zhou G; Luo Q; Luo S; Teng Z; Ji Z; Yang J; Wang F; Wen S; Ding Z; Li L; Chen T; Abi ME; Jian M; Luo L; Liu A; Bao F
    Lancet Infect Dis; 2020 Dec; 20(12):1457-1469. PubMed ID: 32673595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interferon-gamma release assays and tuberculin skin testing for diagnosing latent Mycobacterium tuberculosis infection in at-risk groups in Poland.
    Kruczak K; Mastalerz L; Sładek K
    Int J Mycobacteriol; 2016 Mar; 5(1):27-33. PubMed ID: 26927987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative study of concordance and costs between tuberculin skin test and QuantiFERON(®)-TB Gold In-Tube in the diagnosis of latent tuberculosis infection among contacts of patients with pulmonary tuberculosis].
    Martinez Lacasa X; Canals Font R; Jaen Manzanera A; Cuchi Burgos E; Lite Lite J
    Med Clin (Barc); 2015 Nov; 145(10):427-32. PubMed ID: 25794770
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The performance of quantiferon-TB gold in-tube (QFT-IT) test compared to tuberculin skin test (TST) in detecting latent tuberculosis infection (LTBI) in the presence of HIV coinfection in a high TB-burden area with BCG-vaccinated population.
    James PM; Ganaie FA; Kadahalli RL
    J Int Assoc Provid AIDS Care; 2014; 13(1):47-55. PubMed ID: 23482341
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube, and T-SPOT.TB among patients with tuberculosis.
    Takeda K; Nagai H; Suzukawa M; Sekiguchi R; Akashi S; Sato R; Narumoto O; Kawashima M; Suzuki J; Ohshima N; Yamane A; Tamura A; Matsui H; Tohma S
    J Infect Chemother; 2020 Nov; 26(11):1205-1212. PubMed ID: 32698989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.